Sign in

    FMC Corp (FMC)

    Board Change

    You might also like

    FMC Corporation is a global agricultural sciences company dedicated to assisting growers in producing food, feed, fiber, and fuel while adapting to environmental changes. The company operates in a single business segment, focusing on the development, marketing, and sale of crop protection chemicals, including insecticides, herbicides, and fungicides, as well as biologicals, crop nutrition, and seed treatment products, collectively known as plant health . FMC's portfolio is primarily composed of insecticides and herbicides, with a smaller but growing segment of fungicides and plant health products, which are used to enhance crop yield and quality by controlling pests, weeds, and diseases . The company also invests in innovative technologies and new product formulations to maintain its competitive edge in the agrochemical industry .

    1. Insecticides - Develops and markets chemicals that protect crops by controlling insect pests, contributing significantly to the company's revenue.
    2. Herbicides - Offers solutions for weed control, helping to improve crop yield and quality by eliminating unwanted vegetation.
    3. Fungicides - Provides products that prevent and control fungal diseases, ensuring healthier crops and better yields.
    4. Plant Health Products - Includes biologicals, crop nutrition, and seed treatment products aimed at enhancing overall plant health and productivity.
    NamePositionStart DateShort Bio
    Mark A. DouglasPresident, Chief Executive Officer, and DirectorJune 1, 2020Mark A. Douglas has been serving as the President, CEO, and Director of FMC Corporation since June 1, 2020. He joined FMC in March 2010 and has held several key positions, including President of the Agricultural Solutions business .
    Andrew D. SandiferExecutive Vice President and Chief Financial Officer2018Andrew D. Sandifer has been the EVP and CFO of FMC since 2018. He previously served as Vice President and Treasurer from 2016 to 2018, and as Vice President, Corporate Transformation from 2014 to 2016 .
    Ronaldo PereiraExecutive Vice President and President, FMC Americas2021Ronaldo Pereira has been the EVP and President of FMC Americas since 2021. He previously served as President of FMC Americas from 2019 to 2021 and Vice President of FMC LATAM from 2017 to 2019 .
    Michael F. ReillyExecutive Vice President, General Counsel, Chief Compliance Officer, and Secretary2019Michael F. Reilly has been the EVP, General Counsel, Chief Compliance Officer, and Secretary at FMC since 2019. He previously served as Vice President, Associate General Counsel, and Chief Compliance Officer from 2016 to 2019 .
    Diane AllemangExecutive Vice President and Chief Marketing Officer2021Diane Allemang has been the EVP and Chief Marketing Officer at FMC since 2021. She previously served as Vice President and Chief Marketing Officer from 2018 to 2021 .
    Jacqueline ScanlanExecutive Vice President and Chief Human Resources OfficerSeptember 25, 2023Jacqueline Scanlan joined FMC as the EVP and Chief Human Resources Officer on September 25, 2023. She previously held senior HR positions at Axalta and Haemonetics .
    Vsevolod RostovtsevExecutive Vice President and Chief Technology Officer2023Vsevolod Rostovtsev has been the EVP and Chief Technology Officer at FMC since 2023. He previously served as the Director of Discovery Chemistry for Agricultural Solutions from 2017 to 2023 .
    Thaisa HugenneyerExecutive Vice President, Integrated Supply ChainMarch 1, 2024Thaisa Hugenneyer will serve as the EVP, Integrated Supply Chain at FMC starting March 1, 2024 .
    Brian P. AngeliExecutive Vice President and Chief Marketing OfficerMay 1, 2024Brian P. Angeli will serve as the EVP and Chief Marketing Officer at FMC starting May 1, 2024 .
    1. Given that you were late in adjusting pricing in Latin America and may have lost market share to competitors, how do you plan to regain this market share while maintaining profitability in such a challenging pricing environment?
    2. With Rynaxypyr experiencing low single-digit global declines driven by challenges in Asia, what specific strategies are you implementing to reverse this trend and drive growth for this key product?
    3. You mentioned potential challenges with pricing in 2025 but have not made specific assumptions yet; how do you plan to mitigate the risk of price erosion impacting your target of 6% revenue growth next year?
    4. Following the bankruptcy of a large distributor in Latin America, how does this affect your distribution strategy in the region, and what measures are you taking to reduce similar risks in the future?
    5. With uncertainties surrounding diamide sales in 2025 due to ongoing negotiations and market conditions, how confident are you in meeting your earnings growth projections, and what contingencies are in place if diamide growth underperforms?
    Program DetailsProgram 1
    Approval DateFebruary 2022
    End Date/DurationSeptember 30, 2025
    Total additional amount$1 billion
    Remaining authorization amount$825 million
    DetailsThe program aims to manage capital structure and return value to shareholders. It includes repurchases to offset dilution from share-based compensation. No specific timetable or price targets are set.
    YearAmount Due (in Millions)Debt TypeInterest Rate (%)% of Total Debt
    2024$101.0Short-term foreign debt13.42.5% = (101.0 / 4,070.0) * 100
    2024$856.2Commercial paper5.721.0% = (856.2 / 4,070.0) * 100
    2024$86.0Current portion of long-term debt12.2 - 17.42.1% = (86.0 / 4,070.0) * 100
    2026-2053$2,998.3Senior notes3.2 - 6.473.6% = (2,998.3 / 4,070.0) * 100
    2032$49.9Pollution control and industrial revenue bonds6.451.2% = (49.9 / 4,070.0) * 100
    NameStart DateEnd DateReason for Change
    KPMG LLP1928 PresentCurrent auditor

    Recent developments and announcements about FMC.

    Corporate Leadership

      Board Change

      ·
      Dec 12, 2024, 10:08 PM

      Anthony DiSilvestro has been elected as a director of the FMC Corporation's Board of Directors, effective December 12, 2024. He will serve on the Audit Committee and the Compensation and Human Capital Committee .

      Leadership Change

      ·
      Dec 11, 2024, 10:08 PM

      Pierre R. Brondeau is leaving his position as Chairman and Chief Executive Officer of FMC Corporation. The departure is part of an executive severance plan adopted by the company's Compensation Committee. Andrew D. Sandifer will remain as Executive Vice President and Chief Financial Officer, with his existing severance agreement still in effect. The plan includes severance benefits for executives terminated without cause or for good reason, with different terms depending on whether the termination occurs during a change in control period .